Need professional-grade analysis? Visit stockanalysis.com
$45.50M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Precipio Inc (PRPO) Price Performance
Precipio Inc (PRPO) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $26.57, down 6.10% from the previous close.
Over the past year, PRPO has traded between a low of $5.75 and a high of $29.49. The stock has gained 245.1% over this period. It is currently 9.9% below its 52-week high.
Precipio Inc has a market capitalization of $45.50M.
About Precipio Inc
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Compare Precipio Inc
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $15.20M
- EBITDA
- $-685,000
- Profit Margin
- -5.50%
- EPS (TTM)
- -2.87
- Book Value
- 7.88
Technical Indicators
- 52 Week High
- $29.80
- 52 Week Low
- $5.48
- 50 Day MA
- $25.29
- 200 Day MA
- $20.48
- Beta
- 1.25
Valuation
- Trailing P/E
- N/A
- Forward P/E
- 66.59
- Price/Sales
- 2.00
- Price/Book
- 3.30
- Enterprise Value
- $47.67M